Autolus Therapeutics PLC logo

Autolus Therapeutics PLC

NAS:AUTL (UK)  
$ 2.37 +0.03 (+1.28%) 11:08 PM EST
P/E:
At Loss
P/B:
1.80
Market Cap:
$ 411.62M
Enterprise V:
$ 149.85M
Volume:
257.91K
Avg Vol (2M):
396.12K
Also Trade In:
Volume:
257.91K
Market Cap $:
411.62M
PE Ratio:
At Loss
Avg Vol (2M):
396.12K
Enterprise Value $:
149.85M
PB Ratio:
1.80

Business Description

Description
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Name Current Vs Industry Vs History
Cash-To-Debt 6.04
Equity-to-Asset 0.51
Debt-to-Equity 0.22
Debt-to-EBITDA -0.34
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.55
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 9.89
9-Day RSI 17.16
14-Day RSI 26.16
6-1 Month Momentum % 75.27
12-1 Month Momentum % 56.37

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.65
Quick Ratio 8.65
Cash Ratio 7.49
Days Sales Outstanding 29.62

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -56.7
Shareholder Yield % -2.32

Financials (Next Earnings Date:2023-11-03 Est.)

AUTL's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AUTL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Autolus Therapeutics PLC Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 7.486
EPS (TTM) ($) -1.19
Beta 1.05
Volatility % 106.04
14-Day RSI 26.16
14-Day ATR ($) 0.176197
20-Day SMA ($) 2.963
12-1 Month Momentum % 56.37
52-Week Range ($) 1.6 - 3.54
Shares Outstanding (Mil) 173.68

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Autolus Therapeutics PLC Filings

Filing Date Document Date Form
No Filing Data

Autolus Therapeutics PLC Stock Events

Event Date Price($)
No Event Data

Autolus Therapeutics PLC Frequently Asked Questions

What is Autolus Therapeutics PLC(AUTL)'s stock price today?
The current price of AUTL is $2.37. The 52 week high of AUTL is $3.54 and 52 week low is $1.60.
When is next earnings date of Autolus Therapeutics PLC(AUTL)?
The next earnings date of Autolus Therapeutics PLC(AUTL) is 2023-11-03 Est..
Does Autolus Therapeutics PLC(AUTL) pay dividends? If so, how much?
Autolus Therapeutics PLC(AUTL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1